136 related articles for article (PubMed ID: 12105315)
21. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
[TBL] [Abstract][Full Text] [Related]
22. Assessment of health state in patients with tinnitus: a comparison of the EQ-5D and HUI mark III.
Maes IH; Joore MA; Cima RF; Vlaeyen JW; Anteunis LJ
Ear Hear; 2011; 32(4):428-35. PubMed ID: 21221004
[TBL] [Abstract][Full Text] [Related]
23. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.
Marra CA; Woolcott JC; Kopec JA; Shojania K; Offer R; Brazier JE; Esdaile JM; Anis AH
Soc Sci Med; 2005 Apr; 60(7):1571-82. PubMed ID: 15652688
[TBL] [Abstract][Full Text] [Related]
24. Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.
Santos-García D; de la Fuente-Fernández R
J Neurol Sci; 2013 Sep; 332(1-2):136-40. PubMed ID: 23890935
[TBL] [Abstract][Full Text] [Related]
25. Quality of life and Parkinson's disease: Philippine translation and validation of the Parkinson's disease questionnaire.
Suratos CTR; Saranza GRM; Sumalapao DEP; Jamora RDG
J Clin Neurosci; 2018 Aug; 54():156-160. PubMed ID: 29907384
[TBL] [Abstract][Full Text] [Related]
26. Does the EQ-5D measure quality of life in schizophrenia?
Halling Hastrup L; Nordentoft M; Hjorthøj C; Gyrd-Hansen D
J Ment Health Policy Econ; 2011 Dec; 14(4):187-96. PubMed ID: 22345360
[TBL] [Abstract][Full Text] [Related]
27. The generic 15D instrument is valid and feasible for measuring health related quality of life in Parkinson's disease.
Haapaniemi TH; Sotaniemi KA; Sintonen H; Taimela E
J Neurol Neurosurg Psychiatry; 2004 Jul; 75(7):976-83. PubMed ID: 15201353
[TBL] [Abstract][Full Text] [Related]
28. VALIDATION AND COMPARISON OF EQ-5D-3L AND SF-6D INSTRUMENTS IN A SPANISH PARKINSON´S DISEASE POPULATION SAMPLE.
Garcia-Gordillo MÁ; Del Pozo-Cruz B; Adsuar JC; Cordero-Ferrera JM; Abellan-Perpiñan JM; Sanchez-Martinez FI
Nutr Hosp; 2015 Dec; 32(6):2808-21. PubMed ID: 26667738
[TBL] [Abstract][Full Text] [Related]
29. Patient-perceived involvement and satisfaction in Parkinson's disease: effect on therapy decisions and quality of life.
Grosset KA; Grosset DG
Mov Disord; 2005 May; 20(5):616-9. PubMed ID: 15719417
[TBL] [Abstract][Full Text] [Related]
30. Comparative responsiveness of Parkinson's disease scales to change over time.
Schrag A; Spottke A; Quinn NP; Dodel R
Mov Disord; 2009 Apr; 24(6):813-8. PubMed ID: 19199355
[TBL] [Abstract][Full Text] [Related]
31. Quality of life outcomes following cervical decompression for coexisting Parkinson's disease and cervical spondylotic myelopathy.
Xiao R; Miller JA; Lubelski D; Alberts JL; Mroz TE; Benzel EC; Krishnaney AA; Machado AG
Spine J; 2016 Nov; 16(11):1358-1366. PubMed ID: 27496286
[TBL] [Abstract][Full Text] [Related]
32. Comparison of FACT- and EQ-5D-based utility scores in cancer.
Pickard AS; Ray S; Ganguli A; Cella D
Value Health; 2012; 15(2):305-11. PubMed ID: 22433762
[TBL] [Abstract][Full Text] [Related]
33. Comparison of Health State Utility Measures in Patients With Head and Neck Cancer.
Noel CW; Lee DJ; Kong Q; Xu W; Simpson C; Brown D; Gilbert RW; Gullane PJ; Irish JC; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):696-703. PubMed ID: 26204439
[TBL] [Abstract][Full Text] [Related]
34. Measuring preference-based quality of life using the EuroQol EQ-5D in patients with cerebral aneurysms.
King JT; Tsevat J; Roberts MS
Neurosurgery; 2009 Sep; 65(3):565-72; discussion 572-3. PubMed ID: 19687702
[TBL] [Abstract][Full Text] [Related]
35. Assessing outcomes for cost-utility analysis in mental health interventions: mapping mental health specific outcome measure GHQ-12 onto EQ-5D-3L.
Lindkvist M; Feldman I
Health Qual Life Outcomes; 2016 Sep; 14(1):134. PubMed ID: 27644119
[TBL] [Abstract][Full Text] [Related]
36. A review of preference-based health-related quality of life questionnaires in spinal cord injury research.
Whitehurst DG; Noonan VK; Dvorak MF; Bryan S
Spinal Cord; 2012 Sep; 50(9):646-54. PubMed ID: 22641255
[TBL] [Abstract][Full Text] [Related]
37. Use of health status measures in patients with low back pain in clinical settings. Comparison of specific, generic and preference-based instruments.
Suarez-Almazor ME; Kendall C; Johnson JA; Skeith K; Vincent D
Rheumatology (Oxford); 2000 Jul; 39(7):783-90. PubMed ID: 10908699
[TBL] [Abstract][Full Text] [Related]
38. Assessing outcomes for cost-utility analysis in depression: comparison of five multi-attribute utility instruments with two depression-specific outcome measures.
Mihalopoulos C; Chen G; Iezzi A; Khan MA; Richardson J
Br J Psychiatry; 2014 Nov; 205(5):390-7. PubMed ID: 25257063
[TBL] [Abstract][Full Text] [Related]
39. Gender differences in disability and health-related quality of life in patients with Parkinson's disease treated with stereotactic surgery.
Hariz GM; Lindberg M; Hariz MI; Bergenheim AT
Acta Neurol Scand; 2003 Jul; 108(1):28-37. PubMed ID: 12807390
[TBL] [Abstract][Full Text] [Related]
40. Accurately measuring the quality and effectiveness of cervical spine surgery in registry efforts: determining the most valid and responsive instruments.
Godil SS; Parker SL; Zuckerman SL; Mendenhall SK; McGirt MJ
Spine J; 2015 Jun; 15(6):1203-9. PubMed ID: 24076442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
